153 related articles for article (PubMed ID: 38183091)
21. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
Li X; Chen S; Lyu X; Tian J
Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
[TBL] [Abstract][Full Text] [Related]
22. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
[TBL] [Abstract][Full Text] [Related]
23. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA.
Aballéa S; Guelfucci F; Wagner J; Khemiri A; Dietz JP; Sobel J; Toumi M
Health Qual Life Outcomes; 2013 Oct; 11():169. PubMed ID: 24119427
[TBL] [Abstract][Full Text] [Related]
24. Mannose-binding lectin and vulvovaginal candidiasis.
Liu F; Liao Q; Liu Z
Int J Gynaecol Obstet; 2006 Jan; 92(1):43-7. PubMed ID: 16256117
[TBL] [Abstract][Full Text] [Related]
25. Vaginal microbiota of women with frequent vulvovaginal candidiasis.
Zhou X; Westman R; Hickey R; Hansmann MA; Kennedy C; Osborn TW; Forney LJ
Infect Immun; 2009 Sep; 77(9):4130-5. PubMed ID: 19528218
[TBL] [Abstract][Full Text] [Related]
26.
Pan Y; Sun Y; Chen L; Cheng Y; Jin P; Zhang W; Zheng L; Liu J; Zhou T; Xu Z; Li C; Kostoulias X; Watson CJ; McGiffin D; Peleg AY; Qu Y
Biofilm; 2023 Dec; 6():100162. PubMed ID: 37941804
[TBL] [Abstract][Full Text] [Related]
27. The Mechanism of IL-17 Regulating Neutrophils Participating in Host Immunity of RVVC Mice.
Shao M; Hou M; Li S; Qi W
Reprod Sci; 2023 Dec; 30(12):3610-3622. PubMed ID: 37438557
[TBL] [Abstract][Full Text] [Related]
28. [Chronic and recurrent vulvovaginal candidiasis].
Kubota T
Nihon Ishinkin Gakkai Zasshi; 1998; 39(4):213-8. PubMed ID: 9795266
[TBL] [Abstract][Full Text] [Related]
29. [Longitudinal analysis of vaginal microbiota in women with recurrent vulvovaginal candidiasis].
Ma X; Cai HH; He Y; Zheng HM; Kang L; Zhou HW; Liu MB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):192-198. PubMed ID: 28219862
[TBL] [Abstract][Full Text] [Related]
30. [Vulvovaginal candidiasis in pregnant women with impaired tolerance for glucose].
Deng QS; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):374-6. PubMed ID: 17697596
[TBL] [Abstract][Full Text] [Related]
31. The role of Human Dectin-1 Y238X Gene Polymorphism in recurrent vulvovaginal candidiasis infections.
Usluogullari B; Gumus I; Gunduz E; Kaygusuz I; Simavli S; Acar M; Oznur M; Gunduz M; Kafali H
Mol Biol Rep; 2014 Oct; 41(10):6763-8. PubMed ID: 25008994
[TBL] [Abstract][Full Text] [Related]
32. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in reproductive-age women in Yunnan, China: a descriptive study.
Zhao T; Xiao X; Xiao L; Wu XM; Yuan T
J Obstet Gynaecol; 2022 Oct; 42(7):3187-3192. PubMed ID: 35947028
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana.
Konadu DG; Owusu-Ofori A; Yidana Z; Boadu F; Iddrisu LF; Adu-Gyasi D; Dosoo D; Awuley RL; Owusu-Agyei S; Asante KP
BMC Pregnancy Childbirth; 2019 Sep; 19(1):341. PubMed ID: 31547803
[TBL] [Abstract][Full Text] [Related]
34. Autovaccines - potent tool against chronic vulvovaginal candidiasis.
Koren J; Zaborska M; Varga I; Zahumensky J; Liptakova A
Bratisl Lek Listy; 2023; 124(6):417-420. PubMed ID: 36876375
[TBL] [Abstract][Full Text] [Related]
35. [Systemic enzyme therapy in the treatment of recurrent vulvovaginal candidiasis].
Unzeitig V; Dvořák V; Hlaváčková O; Malík T; Nový J; Stará A; Skřivánek A; Stěpán J
Ceska Gynekol; 2013 Apr; 78(2):187-94. PubMed ID: 23710984
[TBL] [Abstract][Full Text] [Related]
36. "Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) - A systematic review and meta-analysis".
Siddiqui T; Kumar KA; Iqbal A; Doultani PR; Ashraf T; Eqbal F; Siddiqui SI
Heliyon; 2023 Nov; 9(11):e20495. PubMed ID: 37920530
[TBL] [Abstract][Full Text] [Related]
37. Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasis.
Moshfeghy Z; Tahari S; Janghorban R; Najib FS; Mani A; Sayadi M
J Turk Ger Gynecol Assoc; 2020 Jun; 21(2):90-96. PubMed ID: 31640303
[TBL] [Abstract][Full Text] [Related]
38. Species Distribution and Antifungal Susceptibility Profiles of Isolates from Women with Nonrecurrent and Recurrent Vulvovaginal Candidiasis.
Rolo J; Faria-Gonçalves P; Barata T; Oliveira AS; Gaspar C; Ferreira SS; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Costa-de-Oliveira S; Palmeira-de-Oliveira A
Microb Drug Resist; 2021 Aug; 27(8):1087-1095. PubMed ID: 33646045
[TBL] [Abstract][Full Text] [Related]
39. Recurrent vulvovaginal Candida spp isolates phenotypically express less virulence traits.
Faria-Gonçalves P; Rolo J; Gaspar C; Oliveira AS; Pestana PG; Palmeira-de-Oliveira R; Gonçalves T; Martinez-de-Oliveira J; Palmeira-de-Oliveira A
Microb Pathog; 2020 Nov; 148():104471. PubMed ID: 32871255
[TBL] [Abstract][Full Text] [Related]
40. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana'a city, Yemen.
Abdul-Aziz M; Mahdy MAK; Abdul-Ghani R; Alhilali NA; Al-Mujahed LKA; Alabsi SA; Al-Shawish FAM; Alsarari NJM; Bamashmos W; Abdulwali SJH; Al Karawani M; Almikhlafy AA
BMC Infect Dis; 2019 Oct; 19(1):879. PubMed ID: 31640583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
